SRR15030861
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
8 twins match this tumor's tissue · 2 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | SRR33532822 | — | C | 0.865 |
| 2 | SRR6013498 | — | cohortA1 | 0.859 |
| 3 | BS_JG9JZTA9 | low-grade glioma | — | 0.858 |
| 4 | D06FFD0C-80D4-413D-9C83-62D9C163EDAB | — | — | 0.851 |
| 5 | SRR8942975 | — | — | 0.843 |
| 6 | SRR8942937 | — | — | 0.841 |
| 7 | 9BB56866-4E99-4E8A-A63F-2D4801558F14 | — | — | 0.841 |
| 8 | B9535625-504A-4FCD-B341-2985AE72508A | — | — | 0.840 |
| 9 | BS_M8WP5T16 | low-grade glioma | — | 0.839 |
| 10 | A0396799-AB5C-401F-81FF-7C829A3CF1E4 | — | — | 0.838 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 42 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| INTERFERON_ALPHA_RESPONSE | 0.650 | Inavolisib | — uncovered |
| XENOBIOTIC_METABOLISM | 0.580 | Inavolisib | — uncovered |
| INTERFERON_GAMMA_RESPONSE | 0.550 | Idelalisib | — uncovered |
| COAGULATION | 0.470 | Binimetinib | — uncovered |
| OXIDATIVE_PHOSPHORYLATION | 0.450 | Remibrutinib | — uncovered |
| ADIPOGENESIS | 0.390 | Inavolisib | — uncovered |
| BILE_ACID_METABOLISM | 0.390 | Inavolisib | — uncovered |
| PEROXISOME | 0.390 | Idelalisib | — uncovered |
| FATTY_ACID_METABOLISM | 0.380 | Inavolisib | — uncovered |
| MYC_TARGETS_V2 | 0.380 | Idelalisib | — uncovered |
| REACTIVE_OXYGEN_SPECIES_PATHWAY | 0.360 | Inavolisib | — uncovered |
| ALLOGRAFT_REJECTION | 0.350 | Idelalisib | — uncovered |
| UV_RESPONSE_UP | 0.350 | Idelalisib | — uncovered |
| COMPLEMENT | 0.330 | Inavolisib | — uncovered |
| EPITHELIAL_MESENCHYMAL_TRANSITION | 0.320 | Inavolisib | — uncovered |
| IL6_JAK_STAT3_SIGNALING | 0.320 | Inavolisib | — uncovered |
| MYC_TARGETS_V1 | 0.320 | Inavolisib | — uncovered |
| E2F_TARGETS | 0.300 | Inavolisib | — uncovered |
| APOPTOSIS | 0.290 | Idelalisib | — uncovered |
| DNA_REPAIR | 0.280 | Idelalisib | — uncovered |